The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018. Conference Paper uri icon

Overview

abstract

  • As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.

publication date

  • August 15, 2019

Research

keywords

  • Immunotherapy

Identity

PubMed Central ID

  • PMC6696687

Scopus Document Identifier

  • 85070958115

Digital Object Identifier (DOI)

  • 10.1016/j.immuni.2017.02.001

PubMed ID

  • 31416487

Additional Document Info

volume

  • 7

issue

  • 1